• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的全身免疫失调模型及途径

Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer's Disease.

作者信息

Talwar Puneet, Kushwaha Suman, Gupta Renu, Agarwal Rachna

机构信息

Department of Neurology, Institute of Human Behaviour and Allied Sciences (IHBAS), University of Delhi, Delhi, India.

Department of Microbiology, Institute of Human Behaviour and Allied Sciences (IHBAS), University of Delhi, Delhi, India.

出版信息

Front Aging Neurosci. 2019 Oct 23;11:290. doi: 10.3389/fnagi.2019.00290. eCollection 2019.

DOI:10.3389/fnagi.2019.00290
PMID:31736740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6838686/
Abstract

Alzheimer's disease (AD) still remains an enigma for researchers and clinicians. The onset of AD is insidious, gradually progressive and multifactorial. The recent accumulated scientific evidences suggests that the pathological changes resemble the autoimmune-driven self-sustaining inflammatory process as a result of prolonged oxidative stress and immune dyshomeostasis. Apart from aging, during life span various other factors-mainly environmental, lifestyle, chronic stress, polymicrobial infections and neuroendocrine functions-affect the immune system. Here, we provide crosstalk among "trigger insults/inflammatory stimulus" i.e., polymicrobial infection, chronic stress, pro-inflammatory diet and cholinergic signaling to put forward a "Systemic Immune Dyshomeostasis" model as to connect the events leading to AD development and progression. Our model implicates altered cholinergic signaling and suggests pathological stages with various modifiable risk factors and triggers at different chronological age and stage of cognitive decline. The search of specific autoantibodies for AD which may serve as the suitable blood/CSF biomarkers should be actively pursued for the early diagnosis of AD. The preventive and therapeutic strategies should be directed towards maintaining the normal functioning of the immune system throughout the life span and specific modulation of the immune responses in the brain depending on the stage of changes in brain.

摘要

阿尔茨海默病(AD)对研究人员和临床医生来说仍然是一个谜。AD的发病隐匿、逐渐进展且具有多因素性。最近积累的科学证据表明,由于长期氧化应激和免疫失调,其病理变化类似于自身免疫驱动的自我维持炎症过程。除衰老外,在生命周期中,各种其他因素——主要是环境、生活方式、慢性应激、多种微生物感染和神经内分泌功能——都会影响免疫系统。在此,我们阐述了“触发损伤/炎症刺激”(即多种微生物感染、慢性应激、促炎饮食和胆碱能信号)之间的相互作用,以提出一个“系统性免疫失调”模型,从而将导致AD发生和进展的事件联系起来。我们的模型涉及胆碱能信号改变,并提出了不同病理阶段,以及在认知衰退的不同时间年龄和阶段存在的各种可改变的风险因素和触发因素。应积极寻找可作为合适血液/脑脊液生物标志物的AD特异性自身抗体,用于AD的早期诊断。预防和治疗策略应旨在维持整个生命周期免疫系统的正常功能,并根据大脑变化阶段对大脑中的免疫反应进行特异性调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c742/6838686/4bdc53cae67a/fnagi-11-00290-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c742/6838686/8dd566f9a30f/fnagi-11-00290-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c742/6838686/4bdc53cae67a/fnagi-11-00290-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c742/6838686/8dd566f9a30f/fnagi-11-00290-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c742/6838686/4bdc53cae67a/fnagi-11-00290-g0002.jpg

相似文献

1
Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer's Disease.阿尔茨海默病中的全身免疫失调模型及途径
Front Aging Neurosci. 2019 Oct 23;11:290. doi: 10.3389/fnagi.2019.00290. eCollection 2019.
2
Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition.阿尔茨海默病中的加速炎症性衰老及其与淀粉样蛋白、tau蛋白和认知的关系。
Sci Rep. 2021 Jan 21;11(1):1965. doi: 10.1038/s41598-021-81705-7.
3
Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer's Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis.免疫衰老与衰老:神经炎症是阿尔茨海默病的一个突出特征,并且很可能是神经退行性疾病发病机制的一个促成因素。
J Pers Med. 2022 Nov 2;12(11):1817. doi: 10.3390/jpm12111817.
4
A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.阿尔茨海默病的病理生理学和治疗干预的最新进展。
Curr Pharm Des. 2023;29(43):3428-3441. doi: 10.2174/0113816128264355231121064704.
5
Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.血浆神经元外泌体可作为 HIV 感染和阿尔茨海默病认知障碍的生物标志物。
J Neurovirol. 2019 Oct;25(5):702-709. doi: 10.1007/s13365-018-0695-4. Epub 2019 Jan 4.
6
ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.ACH2.0/E,即传统和非传统阿尔茨海默病的综合理论:起源、进展和治疗策略。
Int J Mol Sci. 2024 May 30;25(11):6036. doi: 10.3390/ijms25116036.
7
Age, Sex and Alzheimer's disease: A longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients.年龄、性别与阿尔茨海默病:对3xTg-AD小鼠的纵向研究揭示了性别特异性疾病轨迹以及阿尔茨海默病患者死后大脑中反映出的炎症反应。
bioRxiv. 2023 Dec 24:2023.12.23.573209. doi: 10.1101/2023.12.23.573209.
8
Current Status of Alzheimer's Disease and Pathological Mechanisms Investigating the Therapeutic Molecular Targets.阿尔茨海默病的现状与治疗分子靶点的病理机制研究。
Curr Mol Med. 2023;23(6):492-508. doi: 10.2174/1566524022666220404112843.
9
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.血清白细胞介素 6、sAXL 和 YKL-40 作为阿尔茨海默病患者脑结构和功能降低的系统相关性标志物:来自 DELCODE 研究的结果。
Alzheimers Res Ther. 2023 Jan 12;15(1):13. doi: 10.1186/s13195-022-01118-0.
10
Age, sex and Alzheimer's disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients.年龄、性别与阿尔茨海默病:3xTg-AD 小鼠的纵向研究揭示了性别特异性疾病轨迹和阿尔茨海默病患者死后大脑中的炎症反应。
Alzheimers Res Ther. 2024 Jun 22;16(1):134. doi: 10.1186/s13195-024-01492-x.

引用本文的文献

1
Human Papillomavirus Positivity and Cognitive Function in Older U.S. Adults: A Cross-Sectional Population-Based Study.美国老年成年人的人乳头瘤病毒阳性与认知功能:一项基于人群的横断面研究。
Pathogens. 2025 May 21;14(5):508. doi: 10.3390/pathogens14050508.
2
pyPAGE: A framework for Addressing biases in gene-set enrichment analysis-A case study on Alzheimer's disease.pyPAGE:一种用于解决基因集富集分析中偏差的框架——以阿尔茨海默病为例。
PLoS Comput Biol. 2024 Sep 5;20(9):e1012346. doi: 10.1371/journal.pcbi.1012346. eCollection 2024 Sep.
3
Vascular Parkinsonism-A Revisit.

本文引用的文献

1
Integrated Genomic Analysis Revealed Associated Genes for Alzheimer's Disease in APOE4 Non-Carriers.整合基因组分析揭示了 APOE4 非携带者阿尔茨海默病的相关基因。
Curr Alzheimer Res. 2019;16(8):753-763. doi: 10.2174/1567205016666190823124724.
2
Aβ42 fibril formation from predominantly oligomeric samples suggests a link between oligomer heterogeneity and fibril polymorphism.主要为寡聚体的样本形成Aβ42原纤维表明寡聚体异质性与原纤维多态性之间存在联系。
R Soc Open Sci. 2019 Jul 10;6(7):190179. doi: 10.1098/rsos.190179. eCollection 2019 Jul.
3
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.
血管性帕金森综合征——再探讨
Ann Indian Acad Neurol. 2024 Jan-Feb;27(1):3-4. doi: 10.4103/aian.aian_234_23. Epub 2023 Oct 13.
4
Role of Cholinergic Signaling in Alzheimer's Disease.胆碱能信号在阿尔茨海默病中的作用。
Molecules. 2022 Mar 10;27(6):1816. doi: 10.3390/molecules27061816.
5
Systematic Review of Different Neuroimaging Correlates in Mild Cognitive Impairment and Alzheimer's Disease.轻度认知障碍与阿尔茨海默病的不同神经影像学相关性的系统评价。
Clin Neuroradiol. 2021 Dec;31(4):953-967. doi: 10.1007/s00062-021-01057-7. Epub 2021 Jul 23.
6
Neuroinflammation in Alzheimer's Disease.阿尔茨海默病中的神经炎症
Biomedicines. 2021 May 7;9(5):524. doi: 10.3390/biomedicines9050524.
7
Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.药物纳米靶向治疗痴呆:新冠疫情对痴呆影响的相关性。
Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520976761. doi: 10.1177/1533317520976761.
8
Network Simulations Reveal Molecular Signatures of Vulnerability to Age-Dependent Stress and Tau Accumulation.网络模拟揭示了对年龄依赖性应激和tau蛋白积累易感性的分子特征。
Front Mol Biosci. 2020 Oct 20;7:590045. doi: 10.3389/fmolb.2020.590045. eCollection 2020.
9
Biomimetic Nanocarrier Targeting Drug(s) to Upstream-Receptor Mechanisms in Dementia: Focusing on Linking Pathogenic Cascades.仿生纳米载体将药物靶向痴呆症的上游受体机制:聚焦于连接致病级联反应。
Biomimetics (Basel). 2020 Mar 20;5(1):11. doi: 10.3390/biomimetics5010011.
载脂蛋白 E 与阿尔茨海默病:发病机制与靶向治疗策略。
Nat Rev Neurol. 2019 Sep;15(9):501-518. doi: 10.1038/s41582-019-0228-7. Epub 2019 Jul 31.
4
Physician-Training Stress and Accelerated Cellular Aging.医生培训压力与细胞加速衰老。
Biol Psychiatry. 2019 Nov 1;86(9):725-730. doi: 10.1016/j.biopsych.2019.04.030. Epub 2019 May 9.
5
Social-Stress-Responsive Microbiota Induces Stimulation of Self-Reactive Effector T Helper Cells.社会应激反应性微生物群诱导自身反应性效应辅助性T细胞的刺激。
mSystems. 2019 May 14;4(4). doi: 10.1128/mSystems.00292-18. eCollection 2019 Jul-Aug.
6
The role of gut microbiota in pathogenesis of Alzheimer's disease.肠道微生物群在阿尔茨海默病发病机制中的作用。
J Appl Microbiol. 2019 Oct;127(4):954-967. doi: 10.1111/jam.14264. Epub 2019 Apr 15.
7
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease.新开发的可逆 MAO-B 抑制剂克服了阿尔茨海默病中不可逆抑制剂的缺点。
Sci Adv. 2019 Mar 20;5(3):eaav0316. doi: 10.1126/sciadv.aav0316. eCollection 2019 Mar.
8
Beyond the sleep-amyloid interactions in Alzheimer's disease pathogenesis.阿尔茨海默病发病机制中睡眠-淀粉样蛋白相互作用之外的研究进展。
J Neurophysiol. 2019 Jul 1;122(1):1-4. doi: 10.1152/jn.00118.2019. Epub 2019 Mar 13.
9
ProNGF and Neurodegeneration in Alzheimer's Disease.前神经生长因子与阿尔茨海默病中的神经退行性变
Front Neurosci. 2019 Feb 22;13:129. doi: 10.3389/fnins.2019.00129. eCollection 2019.
10
The Brain NGF Metabolic Pathway in Health and in Alzheimer's Pathology.健康与阿尔茨海默病病理学中的脑源性神经营养因子代谢途径
Front Neurosci. 2019 Feb 12;13:62. doi: 10.3389/fnins.2019.00062. eCollection 2019.